US Bancorp’s Nutraceutical International Co NUTR Stock Holding History

US Bancorp’s Portfolio NUTR Stock Details NUTR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-75	Closed	-$2K	–	3692
2017 Q1	$2K	Buy	+75	New	+$2.54K	﹤0.01%	3438

Other funds holding NUTR

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

WIC

Water Island Capital New York $1.08B AUM 105.75% 1-Year Est. Return

Gabelli Funds Rye, New York $15.7B AUM 36.4% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

US Bancorp's NUTR Position: Q2 2017 in Review

US Bancorp sold out of Nutraceutical International Co (NUTR) in Q2 2017, closing a stake of 75 shares — an estimated $2K sold.

US Bancorp first reported a position in NUTR in Q1 2017 and held it in 1 quarter. The position peaked at $2K in Q1 2017. 86 funds tracked by Wall St. Rank hold NUTR as of Q2 2017.

US Bancorp reported no remaining Nutraceutical International Co position as of Q2 2017 after selling out during the quarter.
US Bancorp sold 75 Nutraceutical International Co shares in Q2 2017, an estimated $2K.
US Bancorp first reported a position in Nutraceutical International Co in Q1 2017 and held it in 1 quarter.
US Bancorp's Nutraceutical International Co position peaked at $2K in Q1 2017.
86 funds tracked by Wall St. Rank held Nutraceutical International Co as of Q2 2017.

Based on US Bancorp's 13F filing for Q2 2017, filed 20 Jul 2017.